Skip to main content
OpenTrials
Completed

NCT Number: NCT01508299

Skin Prick Test for the Diagnosis of Food Allergy- a Comparison of Different Commercial Extracts and Raw Food

Immediate food allergy is , sometimes , a life threatening situation . Diagnosis is done by skin prick test with commercial extracts. Nevertheless, some of the extracts are not optimal and reproduce false negative results (no allergy) in patients with history highly suggestive of allergic reaction. The aim of this study is to compare the reproducibility of different commercial extracts and raw food in patients with convincing history of acute allergic symptoms related to food .

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 month–120 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Allergy and clinical immunology unit , Meir hospital

Kfar Saba, Israel, 44281

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected immediate allergic reaction to food

Exclusion criteria

none

Treatment and study plan

skin test

Procedure

skin test with the Suspected raw food

Primary outcomes

  1. correlation between the results of skin test with commercial extracts and raw food

    Time frame: immediate

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jan 11, 2012
Registry last updated
Oct 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.